GlaxoSmithKline approved to sell bird flu vaccine in Europe
Monday, May 19, 2008 - 10:42
in Health & Medicine
British drugmaker GlaxoSmithKline says it has received regulatory approval to sell its H5N1 bird flu vaccine to European countries.